The conserved regions were selected and divided the rFm-Fortilin (FL) into three fragments, namely rFm-Fortilin (F12), rFm-Fortilin (F2), and rFm-Fortilin (F23) to find the proliferative region, histamine-releasing region, or cancer-related region that may contain. This evidence concerns the gene TPT1 and cancer.